A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers.
Swiss Med Wkly., Jan;131(1-2):10-3 (2001)
Role of the cytoplasmic domain of the beta-subunit of integrin alpha(v)beta6 in infection by foot-and-mouth disease virus.
J. Virol., May;75(9):4158-64 (2001)
Recombinant vaccinia viruses carrying the N gene of human respiratory syncytial virus: studies of gene expression in cell culture and immune response in mice.
J. Virol., Sep;61(9):2885-90 (1987)
Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus.
J. Virol., Dec;61(12):3855-61 (1987)
Preferred sites of recombination in poliovirus RNA: an analysis of 40 intertypic cross-over sequences.
Nucleic Acids Res., Dec;16(24):11705-23 (1988)
Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing.
Virology., Nov;173(1):35-45 (1989)
Intracellular expression and processing of foot-and-mouth disease virus capsid precursors using vaccinia virus vectors: influence of the L protease.
Virology., Jun;176(2):524-30 (1990)
Synthesis of foot-and-mouth disease virus capsid proteins in insect cells using baculovirus expression vectors.
J. Gen. Virol., Aug;71 ( Pt 8):1703-11 (1990)
Myristoylation of foot-and-mouth disease virus capsid protein precursors is independent of other viral proteins and occurs in both mammalian and insect cells.
J. Gen. Virol., Mar;72 ( Pt 3):747-51 (1991)
Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence.
J. Gen. Virol., Nov;72 ( Pt 11):2727-32 (1991)
Polylactosaminoglycan modification of the respiratory syncytial virus small hydrophobic (SH) protein: a conserved feature among human and bovine respiratory syncytial viruses.
Virology., Nov;191(1):417-30 (1992)
The epithelial integrin alphavbeta6 is a receptor for foot-and-mouth disease virus.
J. Virol., Jun;74(11):4949-56 (2000)
Viral RNA modulates the acid sensitivity of foot-and-mouth disease virus capsids.
J. Virol., Jan;69(1):430-8 (1995)
Assembly of foot-and-mouth disease virus empty capsids synthesized by a vaccinia virus expression system.
J. Gen. Virol., Dec;76 ( Pt 12):3089-98 (1995)
Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.
J. Virol., Aug;70(8):5282-7 (1996)
Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.
J. Virol., Nov;71(11):8357-61 (1997)
The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.
EMBO J., Feb;18(3):543-54 (1999)
Foot-and-mouth disease virus is a ligand for the high-affinity binding conformation of integrin alpha5beta1: influence of the leucine residue within the RGDL motif on selectivity of integrin binding.
J. Gen. Virol., May;81(Pt 5):1383-91 (2000)
Replication-competent foot-and-mouth disease virus RNAs lacking capsid coding sequences.
J. Gen. Virol., Jul;81(Pt 7):1699-702 (2000)
Functional discovery via a compendium of expression profiles.
Cell., Jul;102(1):109-26 (2000)